NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
22/12/2025
Voltar para busca
Dado oficial do USPTO
TCF
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
23/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
13/06/2014
Data de registro
23/02/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/12/2025
Última transação
23/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
US
Examinador
ALTREE,NICHOLAS
Localização atual
Historical data usage
Titulares e representantes
Titulares
Kite Pharma, Inc.
Kite Pharma EU B.V.
D. B. (pessoa física)
Representantes
Cynthia Smuzynska GILEAD SCIENCES INC.,
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical preparations for industrial and scientific usepolypeptides and proteins made by genetic engineeringincluding fusion proteins as well as nucleic acids encoding these polypeptides and proteinsbody cells and cells of the immune system of mammalsincluding human cells; analytical kits consisting of chemical reagents for industrial and scientific usefor the purificationdetection and immobilization of fusion proteinsfusion peptides and cellsbody cells and cells of the immune system of mammalsincluding human cells; diagnostic preparations except for medical purposes
Classe 5
pharmaceutical and veterinary preparations for the treatment of cancerincluding hematologic cancersviral mediated diseasesbacterial mediated diseasesinflammatory and autoimmune diseasesincluding rheumatoid arthritisosteoarthritisCrohn's diseasepsoriasispsoriatic arthritispolypeptides and proteins made by genetic engineeringincluding fusion proteinscellsbody cells and cells of the immune system of mammalsincluding human cells ; diagnostic preparations for medical purposes
Classe 42
Scientific and industrial research in the field of biochemistrydiagnostics and pharmaceutics; biochemical or pharmaceutical laboratory servicessynthesis of recombinant polypeptides and proteinscultivation and purification of cellsof body cells and cells of the immune system of mammals including human cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
22/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/12/2025
ES71
TEAS SECTION 71 RECEIVED
01/08/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
23/02/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
15/03/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/09/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
23/07/2023
INPC
INVALIDATION PROCESSED
23/07/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
19/06/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
19/10/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
19/10/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
19/07/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
18/02/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
15/02/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/04/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/02/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/07/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/05/2016
FIMP
FINAL DISPOSITION PROCESSED
25/05/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/05/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
23/02/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/12/2015
PUBO
PUBLISHED FOR OPPOSITION
08/12/2015
GPNX
NOTIFICATION PROCESSED BY IB
04/12/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/11/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/11/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/11/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/10/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/10/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
30/07/2015
CHLD
CHANGE OF OWNER RECEIVED FROM IB
14/05/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/04/2015
GNRT
NON-FINAL ACTION E-MAILED
16/04/2015
CNRT
NON-FINAL ACTION WRITTEN
16/04/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2015
ALIE
ASSIGNED TO LIE
09/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2015
RFNT
REFUSAL PROCESSED BY IB
24/10/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2014
RFRR
REFUSAL PROCESSED BY MPU
08/10/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/10/2014
CNRT
NON-FINAL ACTION WRITTEN
07/10/2014
MAFR
APPLICATION FILING RECEIPT MAILED
04/10/2014
DOCK
ASSIGNED TO EXAMINER
30/09/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/09/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/09/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TCF ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.